Colorectal cancer is one of the commonest cancers in the world and it is also a common
cause of cancer-related death worldwide. Despite advanced treatment strategies, the …

Cancer stem cells are a subset of cells that are responsible for cancer initiation and relapse.
They are generally resistant to the current anticancer agents. Successful anticancer therapy …

Curcumin is a well-known dietary polyphenol derived from the rhizomes of turmeric, an
Indian spice. The anticancer effect of curcumin has been demonstrated in many cell and …

Colorectal cancer (CRC) is one of most common malignancies worldwide and its incidence
is still growing. In spite of recent advances in targeted therapies, their clinical efficacy has …

Colorectal cancer (CRC) is the third most common cause of cancer‐related deaths
worldwide. Hence there is a need to identify new therapeutic agents that improve the current …

Colorectal cancer (CRC) is one of the most common and reoccurring diseases, as well as
the world's second largest cause of mortality. Despite existing preventative, diagnostic, and …

Curcumin is a polyphenol derived from Curcuma longa. Over the last few years, a number of
studies have provided evidence of its main pharmacological properties including …

Colorectal cancer (CRC) is the third most prevalent form of cancer, after lung cancer and
breast cancer, with the second highest death incidence. Over the years, natural compounds …

In vitro and pre-clinical studies have suggested that addition of the diet-derived agent
curcumin may provide a suitable adjunct to enhance efficacy of chemotherapy in models of …

Resistance to conventional chemotherapeutic agents, including irinotecan (CPT‑11), 5-
fluorouracil and capecitabine is a major cause for therapeutic failure in patients with …